secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aldeyra Therapeutics, Inc. (ALDX)
CIK:        0001341235
Form:       8-K
Filed at:   2025-12-31T23:59:59+00:00
Accession:  0001193125-25-338394
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aldeyra CDO Stephen Machatha resigns; transition through March 2026 with $176K severance
--------------------------------------------------------------------------------

- Chief Development Officer Stephen G. Machatha voluntarily resigns effective on/before March 31, 2026.
- Machatha to remain employed through transition period to ensure smooth handoff.
- Severance includes $88K lump sum (50% of 2025 bonus at 110% of target) plus another $88K on release.
- No dispute with management cited as reason for departure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1341235/000119312525338394/0001193125-25-338394-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1341235/000119312525338394/d69806d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-338394

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer